Table 2 Univariate analysis and multivariate analysis of various progression in patients with OSCC Cox-regression analysis
| Â | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
P value | HR | 95% CI | P value | HR | 95% CI | |
CASC9 | 0.025* | 0.558 | 0.335–0.930 | 0.023* | 2.31 | 1.123–4.752 |
Age | 0.758 | 0.951 | 0.693–1.306 | 0.832 | 1.045 | 0.695–1.572 |
Gender | 0.652 | 0.897 | 0.561–1.437 | 0.467 | 0.821 | 0.482–1.398 |
Tumor differentiation | 0.277 | 1.18 | 0.875–1.592 | 0.317 | 1.193 | 0.844–1.687 |
T classification |  < 0.001* | 6.36 | 4.232–9.559 |  < 0.001* | 3.711 | 2.077–6.631 |
Regional lymph node metastasis |  < 0.001* | 7.832 | 4.274–14.351 | 0.006* | 2.749 | 1.340–5.643 |
Clinical stage |  < 0.001* | 5.092 | 3.439–7.539 | 0.011* | 2.383 | 1.224–4.637 |
Site | 0.902 | 0.984 | 0.767–1.263 | 0.924 | 0.987 | 0.761–1.282 |